Ticiana Leal, Balazs Halmos, Narjust Florez, Wade Thomas Iams, Melissa Lynne Johnson, Sarah B. Goldberg, Xiuning Le, Sonam Puri, Danny Nguyen, Luis E. Raez, Jonathan W. Riess, Joshua K. Sabari, Dave Bjork, Nichelle Stigger, Ronald Tang, Karen Xia, Paul Cifuentes, Farah Shanoon, Illse Leipoldt, Kartik Konduri. "COPERNICUS, a pragmatic phase 2b study of subcutaneous (SC) amivantamab (ami) + chemotherapy (chemo) with enhanced dermatologic adverse event (AE) prophylaxis in
                    <i>EGFR</i>
                    -mutated advanced NSCLC: Interim results.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.8614